Get a Group Membership for your Organization. Free Trial
Library
Pricing
Free TrialLogin

Wk 3, Case 3 - Review

HIDE
PrevNext

Report

HISTORY: High risk screening MRI.
LEFT LOQ breast cancer IDC excised 6 months prior to this exam. Preoperative MRI showed 2 foci of lateral enhancement in the RIGHT breast . Lesion 1 RIGHT breast was a fibroadenoma at US biopsy (UOQ). Lesion 2 was biopsied by MRI guidance and was LCIS (LOQ) which was then excised. Patient status post LEFT breast radiation treatment.

Summary of prior imaging:

Mammography: Post-surgical changes both breasts
Ultrasound: NA
Breast MRI: See above.

FINDINGS

Quality control issues: ☒None ☐Poor/lack contrast bolus ☐Poor fat suppression
☐Susceptibility ☐Movement ☐Other

Background Parenchymal Enhancement: Moderate but asymmetric BPE R>>L
Amount of Fibroglandular Tissue: Extreme fibroglandular tissue

LEFT BREAST

Narrative: 3.5 cm post-surgical seroma with smooth benign peripheral enhancement. No additional lesions.

Left breast lesion 1
Lesion type: Post-surgical change
3.7 cm. Lower outer Quadrant. 7:00 Radian. 6 cm from the nipple

Mass/post-surgical change: Shape:Oval/lobulated. Margins:Circumscribed . Enhancement: Rim. Kinetics: sub threshold
BI-RADS:2: Benign: Routine breast MRI screening if cumulative lifetime risk =>20%

Associated findings LEFT: ☒NONE, ☐Nipple retraction, ☐Nipple involvement, ☐Skin retraction, ☐Skin thickening, ☐Skin invasion-direct, ☐Skin invasion-inflammatory, ☐Pectoral muscle invasion, ☐Chest wall invasion, ☐ Architectural distortion

Non-enhancing findings LEFT: ☒NONE, ☐High ductal signal pre contrast T1, ☐Cyst(s), ☐Hematoma/seroma, ☐Post therapy skin/trabecular thickening, ☐Non-enhancing mass, ☐Architectural distortion, ☐Signal void from clips

Fat containing lesions LEFT: X NONE, ☐Fat necrosis, ☐Hamartoma, Post-operative seroma/hematoma with fat

Lymph nodes LEFT: ☒Normal axillary, ☐Abnormal axillary, ☐ Abnormal internal mammary

RIGHT BREAST

Narrative: Post surgical seroma in the RLOQ at site of LCIS excision. Biopsy proven fibroadenoma containing a clip artifact is in the RUOQ. No additional lesions.

Right breast lesion 1
Lesion type: Mass
1.2 cm. Upper outer Quadrant. 10:00 Radian. 3.5 cm from the nipple

Mass/post-surgical change: Shape:Oval/lobulated. Margins:Circumscribed . Enhancement: Homogenous. Kinetics: delayed-Progressive

BI-RADS:2: Benign: Routine breast MRI screening if cumulative lifetime risk =>20%

Right breast lesion 2
Lesion type: Post-surgical change
3 cm. Lower outer Quadrant. 5:00 Radian. 9 cm from the nipple

Mass/post-surgical change: Shape:Irregular. Margins:Circumscribed . Enhancement: Rim. Kinetics: delayed-subthreshold

BI-RADS:2: Benign: Routine breast MRI screening if cumulative lifetime risk =>20%

Associated findings RIGHT breast: ☒NONE, ☐Nipple retraction, ☐Nipple involvement, ☐Skin retraction, ☐Skin thickening, ☐Skin invasion-direct, ☐Skin invasion-inflammatory, ☐Pectoral muscle invasion, ☐Chest wall invasion, ☐ Architectural distortion

Non-enhancing findings RIGHT breast: ☒NONE, ☐High ductal signal pre contrast T1, ☐Cyst(s), ☐Hematoma/seroma, ☐Post therapy skin/trabecular thickening,
☐Non-enhancing mass, ☐Architectural distortion, ☐Signal void from clips

Fat containing lesions RIGHT: ☒NONE, ☐Fat necrosis, ☐Hamartoma, ☐Post-operative seroma/hematoma with fat

Lymph nodes RIGHT: ☒Normal axillary, ☐Abnormal axillary, ☐ Abnormal internal mammary

Extramammary findings: None

SUMMARY

LEFT BI-RADS:2: Benign: Routine breast MRI screening if cumulative lifetime risk =>20%
RIGHT BI-RADS:2: Benign

RECOMMENDATIONS: Continue high risk annual screening with MRI and Mammography

Case Discussion

Faculty

Petra J Lewis, MBBS

Professor of Radiology and OBGYN

Dartmouth-Hitchcock Medical Center & Geisel School of Medicine at Dartmouth

Sheryl G. Jordan, MD

Professor, Department of Radiology

University of North Carolina School of Medicine

Ryan W. Woods, MD, MPH

Assistant Professor of Radiology

University of Wisconsin School of Medicine and Public Health

Tags

Women's Health

MRI

Breast

© 2024 MRI Online. All Rights Reserved.

Contact UsTerms of UsePrivacy Policy